Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.95 USD | -2.17% | -9.01% | +9.51% |
Apr. 16 | Health Care Ticks Up After UnitedHealth Earnings -- Health Care Roundup | DJ |
Apr. 16 | ProPhase Labs, Inc. Unveils Project ZenQ-AI | CI |
Financials (USD)
Sales 2024 * | 54.79M | Sales 2025 * | 138M | Capitalization | 89.32M |
---|---|---|---|---|---|
Net income 2024 * | -14M | Net income 2025 * | 11M | EV / Sales 2024 * | 1.63 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.65 x |
P/E ratio 2024 * |
-6
x | P/E ratio 2025 * |
10.3
x | Employees | 113 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 38.03% |
Latest transcript on ProPhase Labs, Inc.
1 day | -2.17% | ||
1 week | -9.01% | ||
Current month | -23.49% | ||
1 month | -20.16% | ||
3 months | +0.41% | ||
6 months | +9.51% | ||
Current year | +9.51% |
Managers | Title | Age | Since |
---|---|---|---|
Ted Karkus
CEO | Chief Executive Officer | 64 | 09-06-14 |
Chief Operating Officer | 50 | Dec. 31 | |
Robert Morse
AUD | Comptroller/Controller/Auditor | 49 | 22-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Louis Gleckel
BRD | Director/Board Member | 68 | 09-05-31 |
Ted Karkus
CEO | Chief Executive Officer | 64 | 09-06-14 |
Jason Barr
BRD | Director/Board Member | 44 | 15-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.20% | 27 M€ | -5.44% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 4.95 | -2.17% | 12,151 |
24-04-24 | 5.06 | -1.94% | 15,554 |
24-04-23 | 5.16 | +5.31% | 16,630 |
24-04-22 | 4.9 | -6.84% | 62,107 |
24-04-19 | 5.26 | -3.31% | 99,267 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.51% | 89.32M | |
-17.89% | 8.36B | |
+40.49% | 3.6B | |
-32.64% | 2.73B | |
-7.88% | 2.47B | |
-7.31% | 2.32B | |
-14.40% | 1.77B | |
-18.74% | 1.55B | |
-40.19% | 1.22B | |
+5.57% | 1.09B |
- Stock Market
- Equities
- PRPH Stock